Angiotensin Converting Enzymes Inhibitors Market
According to Intent Market Research, the Angiotensin Converting Enzymes (ACE) Inhibitors Market is expected to grow from USD 2.8 Billion in 2024-e at a CAGR of 7.3% to touch USD 4.5 Billion by 2030. The Angiotensin Converting Enzymes (ACE) Inhibitors Market is dominated by key players such as, Novartis, Sanofi S.A., Merck & Co., Inc., Pfizer Inc., Eli Lilly and Company, and AstraZeneca.